AUTL logo

Autolus Therapeutics (AUTL) Company Overview

Profile

Full Name:

Autolus Therapeutics plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

June 22, 2018

Indexes:

Not included

Description:

Autolus Therapeutics is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They create engineered T-cell therapies that target specific cancer cells, aiming to improve patient outcomes and provide new options for those with difficult-to-treat cancers.

Key Details

Price

$1.98

Annual Revenue

$1.70 M(-72.59% YoY)

Annual EPS

-$1.20(+23.57% YoY)

Annual ROE

-101.61%

Beta

1.34

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 Needham
Buy
Dec 9, 24 Needham
Buy
Dec 5, 24 Needham
Buy
Nov 18, 24 Goldman Sachs
Buy
Nov 15, 24 Redburn Atlantic
Buy
Nov 13, 24 Needham
Buy
Nov 12, 24 Needham
Buy
Nov 11, 24 Needham
Buy
Jun 17, 24 Needham
Buy
Jun 3, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Autolus Therapeutics?
  • Does Autolus Therapeutics pay dividends?
  • What sector is Autolus Therapeutics in?
  • What industry is Autolus Therapeutics in?
  • What country is Autolus Therapeutics based in?
  • When did Autolus Therapeutics go public?
  • Is Autolus Therapeutics in the S&P 500?
  • Is Autolus Therapeutics in the NASDAQ 100?
  • Is Autolus Therapeutics in the Dow Jones?
  • When was Autolus Therapeutics's last earnings report?
  • When does Autolus Therapeutics report earnings?
  • Should I buy Autolus Therapeutics stock now?

What is the ticker symbol for Autolus Therapeutics?

The ticker symbol for Autolus Therapeutics is NASDAQ:AUTL

Does Autolus Therapeutics pay dividends?

No, Autolus Therapeutics does not pay dividends

What sector is Autolus Therapeutics in?

Autolus Therapeutics is in the Healthcare sector

What industry is Autolus Therapeutics in?

Autolus Therapeutics is in the Biotechnology industry

What country is Autolus Therapeutics based in?

Autolus Therapeutics is headquartered in United Kingdom

When did Autolus Therapeutics go public?

Autolus Therapeutics's initial public offering (IPO) was on June 22, 2018

Is Autolus Therapeutics in the S&P 500?

No, Autolus Therapeutics is not included in the S&P 500 index

Is Autolus Therapeutics in the NASDAQ 100?

No, Autolus Therapeutics is not included in the NASDAQ 100 index

Is Autolus Therapeutics in the Dow Jones?

No, Autolus Therapeutics is not included in the Dow Jones index

When was Autolus Therapeutics's last earnings report?

Autolus Therapeutics's most recent earnings report was on Nov 12, 2024

When does Autolus Therapeutics report earnings?

The next expected earnings date for Autolus Therapeutics is Mar 14, 2025

Should I buy Autolus Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions